// App-Quantinova.ai

TCT-60 : The Impact of Implantation Techniques in Absorb BVS and Xience EES on Lesion-Oriented Outcomes at Complete 5-Year Follow-Up—An AIDA Trial QCA Substudy

Researchers

Presenter

  • Mick Renkens

Principal Investigators

  • Laura Kerkmeijer

  • Robin Kraak

  • Maik Grundeken

  • Martina Nassif

  • Deborah Kalkman

  • Rene Van der Schaaf

  • Sjoerd Hofma

  • Karin Arkenbout

  • Auke Weevers

  • Jan Tijssen

  • Karel Koch

  • Yoshinobu Onuma

  • Patrick Serruys

  • Robbert de Winter

  • Joanna Wykrzykowska

  • Ruben Tijssen

Medical Centers

  • Albert Schweitzer Hospital, Zevenbergen, Netherlands

  • University Medical Center Groningen, Groningen, Netherlands

  • Heart Center, Academic Medical Center, Amsterdam, Netherlands

  • Department of Cardiology, Tergooi Hospital, Blaricum, Netherlands

  • Medical Center Leeuwarden, Leeuwarden, Netherlands

  • Onze Lieve Vrouwe Gasthuis, Amsterdam, Noord-Holland, Netherlands

  • National University of Ireland, Galway, Ireland

Locations

  • Netherlands

  • Ireland

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved